Ballicules › Drugs › Abiraterone
What it is CYP17A1 inhibitor blocking androgen synthesis everywhere, including the tumor; metastatic prostate cancer.
Why this one It blocks adrenal and intratumoral androgen production, which GnRH agents alone do not reach.
What limits it It must be given with prednisone to prevent mineralocorticoid excess — hypertension, hypokalemia and edema. Take on an empty stomach; food raises exposure many-fold.
FDA-approved for
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Metastatic castration-resistant prostate cancer (with prednisone 5 mg BID) adult male 1000 mg QD 1000 mg QD 1000 mg QD
Renal No adjustment needed
Hepatic Mild (Child-Pugh A): no adjustment; moderate (Child-Pugh B): 250 mg QD; severe (Child-Pugh C): do not use.
Instructions Take on an empty stomach — at least 1 hour before or 2 hours after a meal. Swallow tablets whole with water; do not crush or chew. Give concurrently with a GnRH analog, or use after bilateral orchiectomy. Interrupt, reduce, or discontinue for hepatotoxicity per LFT monitoring. Should not be handled by females who are or may become pregnant.
Cautions Mineralocorticoid excess — hypertension, hypokalemia, fluid retention; QT prolongation/Torsades reported with hypokalemia Adrenocortical insufficiency (especially with prednisone withdrawal or stress) Hepatotoxicity, including fulminant hepatitis and acute liver failure Increased fractures and mortality when combined with radium Ra-223 dichloride — not recommended Embryo-fetal toxicity (male fertility/contraception) Severe hypoglycemia when used with thiazolidinediones or repaglinide in diabetics
Adverse reactions Common (≥10%): fatigue, arthralgia, hypertension, nausea, edema, hypokalemia, hot flush, diarrhea, vomiting, upper respiratory infection, cough, headache Labs (>20%): anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, hypokalemia
Pregnancy Not indicated in females; can cause fetal harm and loss of pregnancy (animal data).
Lactation Not indicated in females; no information on presence in human milk.
Principal risk Mineralocorticoid excess unless prednisone is co-given
Cost, est. cash $500–$15,000/month
Generic entry 2018
Classes and tags
Clinical profile
Therapeutic safety burden 2 / 4
Overdose danger 2 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 3 / 4
Legacy pregnancy category Not assigned — PLLR-era drug
Defining liability Thrombotic, metabolic, hepatic, skeletal or reproductive toxicity varies by hormonal target.
Mechanism of action: Abiraterone ballicule
Open Abiraterone in the interactive console ↗
Memory aids: mascots and interaction avatars
“Zytiger is A berated one” Zytiger = Zebra + Tiger hybrid Abiraterone Inhibits CYP17A1: It targets 17α-hydroxylase and C17,20-lyase enzymes
Open Abiraterone in the interactive console ↗